Development and validation of a reversed-phase LC method for analysing potentially counterfeit antimalarial medicines

Journal of Pharmaceutical and Biomedical Analysis

Volumn 42, Issue 1, 2006, Pages 132-135

  Gaudiano, Maria Cristina ^a   Antoniella, Eleonora ^a   Bertocchi, Paola ^a   Valvo, Luisa ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Antimalarials; Counterfeit drugs; Reversed phase liquid chromatography; Screening analysis; Sub standard drugs

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; EXCIPIENT; MEFLOQUINE; QUININE;

ARTICLE; DRUG DETERMINATION; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; TABLET FORMULATION; VALIDATION PROCESS;

ANTIMALARIALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FRAUD; TABLETS;

EID: 33747774113     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.01.059     Document Type: Article

References (10)

1. Frankish H. Lancet 362 (2003) 1730
2. Shakoor O., Taylor R.B., and Behrens R.H. Trop. Med. Int. Health 2 (1997) 839-845
3. Kapp C. Lancet 360 (2002) 1080
4. WHO. Counterfeit Drugs. Guidelines for the Development of Measures to Combat Counterfeit Drugs. WHO/EDM/QSM/99.1 (1999), WHO
5. Aden Abdi Y., Rimoy G., Ericsson O., Alm C., and Massele A.Y. Lancet 346 (1995) 1161
6. Newton P., Proux S., Green M., Smithuis F., Rozendaal J., Prakongpan S., Chotivanich K., Mayxay M., Looareesuwan S., Farrar J., Nosten F., and White N.J. Lancet 357 (2001) 1948-1950
7. Green M.D., Mount D.L., Wirtz R.A., and White N.J. J. Pharm. Biomed. Anal. 24 (2000) 65-70
8. Taylor R.B., Shakoor O., and Behrens R.H. Lancet 346 (1995) 122
9. Petralanda I. Lancet 345 (1995) 1433
10. EMEA 3AQ13a Guideline, Validation of Analytical Procedure: Methodology, 1996.